February 18, 2022
T2 Biosystems Announces Fourth Quarter & Full Year 2021 Financial Results
Full Year 2021 Total Revenue Growth of 55%; Plans to Double Sepsis Revenue and T2Dx InstrumentsLEXINGTON, Mass., Feb. 17, 2022…
Pharmaceuticals, Biotechnology and Life Sciences
Full Year 2021 Total Revenue Growth of 55%; Plans to Double Sepsis Revenue and T2Dx InstrumentsLEXINGTON, Mass., Feb. 17, 2022…
CAMBRIDGE, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the…
NEW HAVEN, Conn., Feb. 17, 2022 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a biopharmaceutical…
CANTON, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on…
– YUSIMRY™ (adalimumab-aqvh), Coherus’ second product, approved by FDA on December 17, 2021 –– BLAs under FDA review for PD-1…
NEWS RELEASE 17 February 2022, 4:00 PM EST / 22:00 CET MDxHealth to Present Fourth Quarter and Full Year 2021…
SOUTH SAN FRANCISCO, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it…
SEATTLE, Feb. 16, 2022 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein…
FREMONT, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the…
Conference Call and Webcast Scheduled for February 24, 2022, 4:30 p.m. ETPRINCETON, N.J., Feb. 16, 2022 (GLOBE NEWSWIRE) — Oyster…